Morgan Stanley crosses Eckert & Ziegler threshold
Analysis based on 11 articles · First reported Jul 10, 2026 · Last updated Jul 14, 2026
The notifications are routine regulatory filings and are unlikely to have a significant impact on Eckert & Ziegler's stock price or Morgan Stanley's operations. The event reflects standard portfolio adjustments by a major financial institution.
Morgan Stanley, through its subsidiaries, has crossed multiple voting rights thresholds in Eckert & Ziegler SE, a German medical technology company, between July 6 and July 8, 2026. The notifications were made under the German Securities Trading Act (WpHG) and show Morgan Stanley's total voting rights (including instruments) ranging from 5.45% to 5.49%. The filings indicate a mix of direct shareholdings and instruments such as equity swaps and securities lending agreements. The exact reason for the changes includes voluntary group notifications and exercise of instruments at the subsidiary level.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard